ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
188 hedge funds and large institutions have $1.74B invested in Intercept Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
18% less capital invested
Capital invested by funds: $2.13B → $1.74B (-$388M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
188
Holding in Top 10
3
Calls
$104M
Puts
$122M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$14.4M | |
| 3 | +$11.9M | |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$10.7M |
| 5 |
BlackRock
New York
|
+$9.69M |
Top Sellers
| 1 | -$40.1M | |
| 2 | -$30.9M | |
| 3 | -$26.5M | |
| 4 |
SC
Samlyn Capital
New York
|
-$18M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$14M |